(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Critical Illness D016638 13 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Encephalopathy, Bovine Spongiform D016643 2 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Diabetic Ketoacidosis D016883 16 associated lipids
Liver Failure D017093 5 associated lipids
Hyperandrogenism D017588 5 associated lipids
Glucose Intolerance D018149 13 associated lipids
Adenocarcinoma, Clear Cell D018262 1 associated lipids
Placenta, Retained D018457 3 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Shutenko ZhV et al. [Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate]. 1991 Mar-Apr Vopr. Med. Khim. pmid:1897198
Balasiavichius RV et al. [Effect of ischemia on the functional activity and membrane permeability of heart mitochondria]. 1984 Mar-Apr Vopr. Med. Khim. pmid:6331001
Keller U et al. Protein-sparing therapy in the postoperative period. 1986 World J Surg pmid:3083595
Hehenberger K et al. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. 1998 Mar-Apr Wound Repair Regen pmid:9776856
Sánchez SF et al. Nutritional condition affects the disposition kinetics of albendazole in cattle. 1996 Xenobiotica pmid:8730922
Jeong HJ et al. The ketogenic diet suppresses the cathepsin E expression induced by kainic acid in the rat brain. 2010 Yonsei Med. J. pmid:20635438
Langhans W et al. [Effect of carbohydrate intake during a long distance run on work capacity and metabolism]. 1992 Z Ernahrungswiss pmid:1585683
Meijer GW and Beynen AC Influence of dietary carnitine on lipid and carbohydrate metabolism in rats. 1988 Z Ernahrungswiss pmid:3206914
Georgieff M et al. [Regulation of ketone body levels before and following elective surgical operations during different intravenous feedings]. 1982 Z Ernahrungswiss pmid:6815908
Silberbauer C et al. Breakfasts with different fiber and macronutrient contents do not differentially affect timing, size or microstructure of the subsequent lunch. 1996 Z Ernahrungswiss pmid:9000333